PRIMAVERA, DIEGO
 Distribuzione geografica
Continente #
EU - Europa 22.804
NA - Nord America 1.411
AS - Asia 195
AF - Africa 7
SA - Sud America 7
OC - Oceania 3
Totale 24.427
Nazione #
IT - Italia 22.421
US - Stati Uniti d'America 1.404
CN - Cina 136
UA - Ucraina 135
SE - Svezia 104
FI - Finlandia 40
GB - Regno Unito 34
DE - Germania 28
SG - Singapore 17
FR - Francia 16
TR - Turchia 12
VN - Vietnam 8
BR - Brasile 7
CA - Canada 7
IE - Irlanda 6
IN - India 6
KR - Corea 6
IR - Iran 4
AU - Australia 3
BE - Belgio 3
CZ - Repubblica Ceca 3
HR - Croazia 3
NL - Olanda 3
BA - Bosnia-Erzegovina 2
NG - Nigeria 2
PK - Pakistan 2
PL - Polonia 2
RS - Serbia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TZ - Tanzania 2
ET - Etiopia 1
JP - Giappone 1
MU - Mauritius 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 24.427
Città #
Cagliari 22.271
Fairfield 176
Woodbridge 164
Chandler 127
Houston 122
Ashburn 100
Wilmington 82
Seattle 76
Jacksonville 67
Cambridge 61
Nyköping 60
Ann Arbor 59
Shanghai 36
Boston 31
New York 31
Boardman 30
Nanjing 22
Dearborn 19
Helsinki 18
Beijing 15
Rome 13
San Diego 12
Milan 11
Arlington 10
Redwood City 10
Washington 9
Dong Ket 8
San Sperate 8
Atlanta 7
Changsha 7
Hebei 7
Sassari 7
Dublin 6
Istanbul 6
Jiaxing 6
London 6
Los Angeles 5
Monserrato 5
Mountain View 5
Quartu Sant'Elena 5
Redmond 5
Shenyang 5
Nanchang 4
Norwalk 4
Prescot 4
Tianjin 4
Toronto 4
Bolton 3
Brussels 3
Chicago 3
Falls Church 3
Guangzhou 3
Kocaeli 3
Maringá 3
Mestre 3
Ningbo 3
Orange 3
San Mateo 3
Seoul 3
Zagreb 3
Amsterdam 2
Auburn Hills 2
Chengdu 2
Cremona 2
Dammam 2
Dar es Salaam 2
Dongguan 2
Hangzhou 2
Hefei 2
Karachi 2
Lagos 2
Montréal 2
Niš 2
Nocera Umbra 2
Phoenix 2
Prague 2
Pune 2
Reggio Emilia 2
Rio de Janeiro 2
Riverside Park 2
Saint-Fons 2
Sarajevo 2
Scarperia e San Piero 2
Xi'an 2
Acton 1
Albuquerque 1
Ankara 1
Baotou 1
Bologna 1
Böblingen 1
Caserta 1
Chiswick 1
Council Bluffs 1
Curcuris 1
Domusnovas Canales 1
Hounslow 1
Huntington Beach 1
Islington 1
Jinan 1
Kilburn 1
Totale 23.853
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 2.547
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.244
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.116
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 1.996
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.647
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.360
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.289
Obesità e qualità della vita 1.051
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 973
Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder? 941
The role of comorbidities in duration of untreated illness for bipolar spectrum disorders 822
Social cognition in people with schizophrenia: A cluster-analytic approach 704
First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services 529
Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders 416
Differenze di genere, sintomi psicopatologici e qualità di vita nei pazienti in trattamento con Interferon: risultati di uno studio prospettico 415
L’intervento all’esordio psicotico incide significativamente sulla remissione clinica ed il recupero funzionale? Dati preliminari di uno studio osservazionale 403
Gender difference, psychopathological symptoms and quality of life in patients with Interferon: results of a prospective study 396
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 360
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 294
Physical activity in the psychiatric patient 291
First-episode Psychosis and Migration in Italy: Results from a Study in the Italian Mental Health Services (Pep-Ita Study) 287
Duration of untreted psychosis and cognitive impairment in schizophrenic spectrum disorders 277
Duration of untreated illness and long-term outcome in major depressive disorder 270
null 264
Is Bipolar Disorder the Consequence of a Genetic Weakness or Not Having Correctly Used a Potential Adaptive Condition? 261
null 250
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 249
Durata di malattia non trattata ed esiti a lungo termine nei disturbi depressivi maggiori 233
Is a Genetic Variant associated with Bipolar Disorder Frequent in People without Bipolar Disorder but with Characteristics of Hyperactivity and Novelty Seeking? 228
The duration of untreated psychosis is associated with an increased number of hospitalizations in the long term outcome 221
A Recovery-Oriented Program for People with Bipolar Disorder through Virtual Reality-Based Cognitive Remediation: Results of a Feasibility Randomized Clinical Trial 174
Insomnia and excessive daytime sleepiness in psychotic patients taking traditional or atypical antipsychotic medications 168
null 132
Development and Validation of the Questionnaire for Adaptive Hyperactivity and Goal Achievement (AHGA) 96
The impact of MDQ positivity on quality of life impairment: Does it support the hypothesis of Dysregulation of Mood, Energy, and Social Rhythms Syndrome (DYMERS)? 91
Respect for human rights as a component of organisational well-being: factor structure analysis in three countries of Latin America 88
Does Screening for Bipolar Disorders Identify a “Dysregulation of Mood, Energy, and Social Rhythms Syndrome” (DYMERS)? A Heuristic Working Hypothesis 87
An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review 77
Psychopathological symptoms and quality of life in patients receiving interferon: results of a prospective study 75
ESORDI PSICOTICI: DIFFERENZE DI GENERE NELL'ETA' DI ESORDIO 72
Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? 66
Durata di psicosi non trattata e deterioramento cognitivo in una coorte di pazienti psicotici cronici 53
Does the Response to a Stressful Condition in Older Adults with Life Rhythm Dysregulations Provide Evidence of the Existence of the “Dysregulation of Mood, Energy, and Social Rhythms Syndrome”? 19
Mental Health Professionals’ Perception of Respect for Human Rights and Organizational Well-Being in Three Countries of South America 15
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 11
Totale 24.558
Categoria #
all - tutte 32.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019173 0 0 0 0 0 0 0 0 0 0 93 80
2019/20205.161 317 158 29 90 1.908 1.338 706 180 110 84 87 154
2020/20216.243 213 277 319 2.014 1.248 598 438 337 108 259 257 175
2021/20221.223 160 89 35 103 127 72 54 63 104 157 145 114
2022/20232.140 155 150 199 142 139 234 143 286 164 130 256 142
2023/20244.625 157 100 361 310 368 1.225 863 343 281 327 290 0
Totale 24.558